Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chai-Gui Jieyu Qufa Granules in Cancer-related Fatigue of Lung Adenocarcinoma
NCT07890051Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer-related fatigue (CRF) comparing Chai-Gui Jieyu Qufa Granules with Chai-Gui Jieyu Qufa Placebo Granules (2 arms). Primary endpoint: Brief Fatigue Inventory at 21 days. Started Jan 2024; status: completed.
02
Drugs
Chai-Gui Jieyu Qufa Granules
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT07890051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07890051.